Intrathecal transplantation of human umbilical cord mesenchymal stem cells enhances spinal cord injury recovery: Role of miR‑124‑3p as a biomarker

Zheng,Yitong; Wang,Yongxin; Liu,Wen; A,Mujite; Li,Yabin; Ma,Xiaohu; Abulimiti,Mieradili; Maimaitiaili,Nuerailijiang; Qin,Hu

doi:10.3892/etm.2025.12807

Intrathecal transplantation of human umbilical cord mesenchymal stem cells enhances spinal cord injury recovery: Role of miR‑124‑3p as a biomarker

Authors:
- Yitong Zheng
- Yongxin Wang
- Wen Liu
- Mujite A
- Yabin Li
- Xiaohu Ma
- Mieradili Abulimiti
- Nuerailijiang Maimaitiaili
- Hu Qin
View Affiliations

Affiliations: Department of Neurosurgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region 830000, P.R. China
Published online on: January 22, 2025 https://doi.org/10.3892/etm.2025.12807
Article Number: 57
Copyright: © Zheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Spinal cord injury (SCI) is a severe condition that often leads to permanent functional impairments. The current treatment options are limited and there is a need for more effective treatments. Human umbilical cord mesenchymal stem cells (hUCMSCs) have shown promise in promoting neuroregeneration and modulating immune response. In addition, miR‑124‑3p has been identified as a potential biomarker for monitoring the progress of neural repair, making it a focus of the present study, which used a rat model of SCI to evaluate the effects of intrathecal hUCMSC transplantation. The present study included three groups: A sham‑operated group, an SCI model group receiving PBS and an SCI group receiving hUCMSCs. Neurological function was assessed using the Basso, Beattie and Bresnahan locomotor rating scale and Rivlin inclined plane test on days 1, 3, 7, 14 and 21 post‑injury. Histological analysis included hematoxylin and eosin staining to assess tissue morphology, Nissl staining to evaluate neuron survival and immunofluorescence to detect bromodeoxyuridine (BrdU)+/neuron‑specific enolase (NSE)+ cells, which indicate neurogenesis. Detection of brain‑derived neurotrophic factor (BDNF) protein expression at various time points in rats with spinal cord injury using western blotting. miR‑124‑3p expression was quantified using reverse transcription‑quantitative (RT‑q)PCR to assess its potential as a biomarker for SCI recovery. The hUCMSC group showed significant improvements in motor function compared with the control group, particularly on days 7 and 14 post‑injury. Histological analysis revealed reduced scar tissue formation and increased neuron survival in the hUCMSC group. Immunofluorescence analysis showed a higher number of BrdU+/NSE+ cells in the hUCMSC group, indicating enhanced neurogenesis. The expression of the neurorepair‑related protein BDNF was markedly higher in the hUCMSCs group compared with the control group. Furthermore, RT‑qPCR analysis demonstrated a marked upregulation of miR‑124‑3p in the hUCMSC group, which was correlated with improved functional recovery. The present study demonstrated that intrathecal transplantation of hUCMSCs notably enhanced recovery following SCI, probably by promoting neurogenesis and modulating miR‑124‑3p expression. miR‑124‑3p upregulation in the hUCMSC group highlighted its potential as a biomarker for tracking the progress of SCI recovery. These findings provided a foundation for the future clinical applications of hUCMSCs in SCI treatment and the use of miR‑124‑3p as a monitoring tool.

View Figures

View References

1	Hu X, Xu W, Ren Y, Wang Z, He X, Huang R, Ma B, Zhao J, Zhu R and Cheng L: Spinal cord injury: Molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 8(245)2023.PubMed/NCBI View Article : Google Scholar
2	Sterner RC and Sterner RM: Immune response following traumatic spinal cord injury: Pathophysiology and therapies. Front Immunol. 13(1084101)2022.PubMed/NCBI View Article : Google Scholar
3	Eli I, Lerner DP and Ghogawala Z: Acute traumatic spinal cord Injury. Neurol Clin. 39:471–488. 2021.PubMed/NCBI View Article : Google Scholar
4	Wang LT, Liu KJ, Sytwu HK, Yen ML and Yen BL: Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Transl Med. 10:1288–1303. 2021.PubMed/NCBI View Article : Google Scholar
5	Li K, Yan G, Huang H, Zheng M, Ma K, Cui X, Lu D, Zheng L, Zhu B, Cheng J and Zhao J: Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages. J Nanobiotechnology. 20(38)2022.PubMed/NCBI View Article : Google Scholar
6	Zhou X, Liu X, Liu L, Han C, Xie Z, Liu X, Xu Y, Li F, Bi J and Zheng C: Transplantation of IFN-γ Primed hUCMSCs significantly improved outcomes of experimental autoimmune encephalomyelitis in a mouse model. Neurochem Res. 45:1510–1517. 2020.PubMed/NCBI View Article : Google Scholar
7	Wei P, Jia M, Kong X, Lyu W, Feng H, Sun X, Li J and Yang JJ: Human umbilical cord-derived mesenchymal stem cells ameliorate perioperative neurocognitive disorder by inhibiting inflammatory responses and activating BDNF/TrkB/CREB signaling pathway in aged mice. Stem Cell Res Ther. 14(263)2023.PubMed/NCBI View Article : Google Scholar
8	Huang J, U KP, Yang F, Ji Z, Lin J, Weng Z, Tsang LL, Merson TD, Ruan YC, Wan C, et al: Human pluripotent stem cell-derived ectomesenchymal stromal cells promote more robust functional recovery than umbilical cord-derived mesenchymal stromal cells after hypoxic-ischaemic brain damage. Theranostics. 12:143–166. 2022.PubMed/NCBI View Article : Google Scholar
9	Wei Z, Hang S, Wiredu Ocansey DK, Zhang Z, Wang B, Zhang X and Mao F: Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis. J Nanobiotechnology. 21(188)2023.PubMed/NCBI View Article : Google Scholar
10	Zhao H, Li Y, Chen L, Shen C, Xiao Z, Xu R, Wang J and Luo Y: HucMSCs-Derived miR-206-knockdown exosomes contribute to neuroprotection in subarachnoid hemorrhage induced early brain injury by targeting BDNF. Neuroscience. 417:11–23. 2019.PubMed/NCBI View Article : Google Scholar
11	Mavroudis I, Balmus IM, Ciobica A, Nicoara MN, Luca AC and Palade DO: The role of microglial exosomes and miR-124-3p in neuroinflammation and neuronal repair after traumatic brain injury. Life (Basel). 13(1924)2023.PubMed/NCBI View Article : Google Scholar
12	Yan Q, Sun SY, Yuan S, Wang XQ and Zhang ZC: Inhibition of microRNA-9-5p and microRNA-128-3p can inhibit ischemic stroke-related cell death in vitro and in vivo. IUBMB Life. 72:2382–2390. 2020.PubMed/NCBI View Article : Google Scholar
13	Cheng Z, Li X, Ye X, Yu R and Deng Y: Purpurogallin reverses neuronal apoptosis and enhances ‘M2’ polarization of microglia under ischemia via mediating the miR-124-3p/TRAF6/NF-κB axis. Neurochem Res. 48:375–392. 2023.PubMed/NCBI View Article : Google Scholar
14	Li R, Zhao K, Ruan Q, Meng C and Yin F: Bone marrow mesenchymal stem cell-derived exosomal microRNA-124-3p attenuates neurological damage in spinal cord ischemia-reperfusion injury by downregulating Ern1 and promoting M2 macrophage polarization. Arthritis Res Ther. 22(75)2020.PubMed/NCBI View Article : Google Scholar
15	Ge X, Guo M, Hu T, Li W, Huang S, Yin Z, Li Y, Chen F, Zhu L, Kang C, et al: Increased microglial exosomal miR-124-3p alleviates neurodegeneration and improves cognitive outcome after rmTBI. Mol Ther. 28:503–522. 2020.PubMed/NCBI View Article : Google Scholar
16	National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the Care and Use of Laboratory Animals. 8th edition. National Academies Press (US), Washington, DC, 2011.
17	Chen JN, Zhang YN, Tian LG, Zhang Y, Li XY and Ning B: Down-regulating circular RNA Prkcsh suppresses the inflammatory response after spinal cord injury. Neural Regen Res. 17:144–151. 2022.PubMed/NCBI View Article : Google Scholar
18	Basso DM, Beattie MS and Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1–21. 1995.PubMed/NCBI View Article : Google Scholar
19	Wang X, Hong CG, Duan R, Pang ZL, Zhang MN, Xie H and Liu ZZ: Transplantation of olfactory mucosa mesenchymal stromal cells repairs spinal cord injury by inducing microglial polarization. Spinal Cord. 62:429–439. 2024.PubMed/NCBI View Article : Google Scholar
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
21	Huang Y, Wu Q and Tam PKH: Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications. Int J Mol Sci. 23(10023)2022.PubMed/NCBI View Article : Google Scholar
22	Zhou H, Shen X, Yan C, Xiong W, Ma Z, Tan Z, Wang J, Li Y, Liu J, Duan A and Liu F: Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage. Stem Cell Res Ther. 13(322)2022.PubMed/NCBI View Article : Google Scholar
23	Toader C, Dobrin N, Brehar FM, Popa C, Covache-Busuioc RA, Glavan LA, Costin HP, Bratu BG, Corlatescu AD, Popa AA and Ciurea AV: From recognition to remedy: The significance of biomarkers in neurodegenerative disease pathology. Int J Mol Sci. 24(16119)2023.PubMed/NCBI View Article : Google Scholar
24	Jiang D, Gong F, Ge X, Lv C, Huang C, Feng S, Zhou Z, Rong Y, Wang J, Ji C, et al: Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytes. J Nanobiotechnology. 18(105)2020.PubMed/NCBI View Article : Google Scholar
25	Wang S, Jia Y, Cao X, Feng S, Na L, Dong H, Gao J and Zhang L: HUCMSCs transplantation combined with ultrashort wave therapy attenuates neuroinflammation in spinal cord injury through NUR77/NF-κB pathway. Life Sci. 267(118958)2021.PubMed/NCBI View Article : Google Scholar
26	Liao Z, Yang X, Wang W, Deng W, Zhang Y, Song A, Ni B, Zhao H, Zhang S and Li Z: hucMSCs transplantation promotes locomotor function recovery, reduces apoptosis and inhibits demyelination after SCI in rats. Neuropeptides. 86(102125)2021.PubMed/NCBI View Article : Google Scholar
27	Liu S, Zhang H, Wang H, Huang J, Yang Y, Li G, Yu K and Yang L: A comparative study of different stem cell transplantation for spinal cord injury: A systematic review and network meta-analysis. World Neurosurg. 159:e232–e243. 2022.PubMed/NCBI View Article : Google Scholar
28	Akhlaghpasand M, Tavanaei R, Hosseinpoor M, Yazdani KO, Soleimani A, Zoshk MY, Soleimani M, Chamanara M, Ghorbani M, Deylami M, et al: Safety and potential effects of intrathecal injection of allogeneic human umbilical cord mesenchymal stem cell-derived exosomes in complete subacute spinal cord injury: A first-in-human, single-arm, open-label, phase I clinical trial. Stem Cell Res Ther. 15(264)2024.PubMed/NCBI View Article : Google Scholar
29	Subbarayan R, Murugan Girija D, Raja STK, Krishnamoorthy A, Srinivasan D, Shrestha R, Srivastava N and Ranga Rao S: Conditioned medium-enriched umbilical cord mesenchymal stem cells: A potential therapeutic strategy for spinal cord injury, unveiling transcriptomic and secretomic insights. Mol Biol Rep. 51(570)2024.PubMed/NCBI View Article : Google Scholar